Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
Tavoschi, L., Mason, L., Petriti, U., Bunge, E., Veldhuijzen, I., Duffell, E.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.
Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.
Kenyon, C., Buyze, J., Spiteri, G., Cole, M.J., Unemo, M.
Human papillomavirus vaccination coverage, policies, and practical implementation across Europe
Nguyen-Huu, N.-H., Thilly, N., Derrough, T., Sdona, E., Claudot, F., Pulcini, C., Agrinier, N.
The effectiveness and cost-effectiveness of screening for and vaccination against hepatitis B virus among migrants in the EU/EEA: A systematic review
Myran, D.T., Morton, R., Biggs, B.-A., Veldhuijzen, I., Castelli, F., Tran, A., Staub, L.P., Agbata, E., Rahman, P., Pareek, M., Noori, T., Pottie, K.
Yellow fever in the diagnostics laboratory review-article
Domingo, C., Charrel, R.N., Schmidt-Chanasit, J., Zeller, H., Reusken, C.
Hepatitis B/C in the countries of the EU/EEA: A systematic review of the prevalence among at-risk groups
Falla, A.M., Hofstraat, S.H.I., Duffell, E., Hahné, S.J.M., Tavoschi, L., Veldhuijzen, I.K.